Telix and Monrol Expand Alliance to Include Lutetium Supply
Telix announces global clinical supply agreement with Monrol for the supply of no carrier added lutetium-177 for use in Telix’s MTR...
Read moreLatest News
Category: ASX
Telix Announces Executive Leadership Appointments and Establishment of Asia Pacific Operating Region
Telix announces several key executive leadership appointments, including the establishment of an Asia-Pacific (APAC) operating region, further continuing the Company’s rapid commercial...
Read more
Telix Pharmaceuticals and Global Medical Solutions Complete Strategic Manufacturing Agreement
Telix announces it has completed a strategic manufacturing agreement with Global Medical Solutions to manufacture and supply finished unit doses of MTR products for clinical development...
Read more
Australian TGA Accepts Telix’s Prostate Cancer Imaging Product Submission and Commences Priority Evaluation Process
Telix announces the Australian Therapeutic Goods Administration has accepted its prostate cancer imaging product submission and commenced the priority evaluation...
Read more
Telix Pharmaceuticals Limited – Notice of Annual General Meeting 2021
Telix Pharmaceuticals provides notice of The Annual General Meeting of Shareholders on Wednesday 12 May...
Read more
Telix Pharmaceuticals and Grand River Aseptic Manufacturing Complete Agreement for Commercial Manufacturing of Illuccix®
Telix announces it has completed an agreement with Grand River Aseptic Manufacturing to perform GMP manufacturing of Telix’s prostate cancer imaging...
Read more
Telix Pharmaceuticals and ITM Complete Global Agreements for Lutetium-177 Radioisotope Supply
Telix announces it has extended its non-exclusive global clinical and commercial supply agreements with Garching-based ITM...
Read more
AUDIO LINK NOT INCLUDED – Telix Pharmaceuticals Releases Results for the Year Ended 31 December 2020 and 2020 Annual Report
Telix Pharmaceuticals Limited Releases Full-Year 2020 Results and 2020 Annual...
Read more
Telix FY2020 Results and Company Update Conference Call
Telix to present the Company’s FY2020 results together with an update on Telix’s...
Read more
Czech Republic Grants National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
Telix announces the Ministry of Health of the Czech Republic is the first European health authority to grant a national authorization allowing the use of...
Read more